Type A behaviour pattern: is it a risk factor for hypertension?

N Al-Asadi1

  • 1Department of Community Medicine, College of Medicine, University of Basra, Basra, Iraq. jasim1951@yahoo.com

Insights

Type A behavior pattern, characterized by competitiveness and impatience, is linked to hypertension. This study found Type A behavior to be an independent risk factor for developing high blood pressure.

Area of Science:

  • Cardiology
  • Psychosomatic Medicine
  • Public Health

Background:

  • Type A behavior pattern (TABP) is associated with coronary heart disease.
  • Previous research on TABP's link to hypertension has yielded inconsistent results.

Purpose of the Study:

  • To investigate the association between Type A behavior pattern and hypertension.
  • To determine if TABP is an independent risk factor for hypertension.

Main Methods:

  • A case-control study was conducted in Basra, Iraq.
  • 221 hypertensive patients and 221 non-hypertensive controls were interviewed using a Type A behavior questionnaire.
  • Blood pressure, height, and weight were measured for all participants.

Main Results:

  • The prevalence of Type A behavior was significantly higher in hypertensive patients (57.5%) compared to controls (24.9%).
  • A strong association was found between Type A behavior and hypertension (Odds Ratio = 4.08, 95% Confidence Interval: 2.72-6.11).

Conclusions:

  • Type A behavior pattern is significantly associated with hypertension.
  • TABP is identified as an independent risk factor for the development of hypertension.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...